Hospitals

Here’s how much outpatient visits have rebounded in May and June, according to a Harvard analysis

June 25, 2020 / by Heather Landi

Ambulatory care practices are beginning to rebound from the staggering 58% drop in patient visits in late March but new data shows that things are far from normal.

Visit numbers have rebounded in May and early June but are still substantially lower than before the U.S. pandemic began, according to an analysis by researchers at Harvard University and health tech company Phreesia.

Researchers analyzed visit volumes for 50,000 providers and found that patient trips to ambulatory practices during the week of June 14 are still down 11% compared to baseline.

The cumulative deficit in visits from March 15 to June 20 is nearly 40%, the analysis shows. The cumulative deficit is the fraction of all visits during this roughly three-month time period that did not occur, researchers said.

While that represents an emerging rebound from the 60% drop in patient visits seen in mid-March, the data indicates that practices still have a long road ahead as they adapt to an evolving pandemic.

After several months of lost visits and revenue, practices are still recovering from closed sites, staff layoffs, and furloughs while trying to assist patients to obtain care that had been delayed.

READ THE REST HERE

Print Friendly, PDF & Email
Tags

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Back to top button
Close